NEOPENDA IN THE NEWS
Tabaka Case Study
At Tabaka Mission Hospital in Kisii, Kenya, nurses once had to care for up to ten critically ill newborns with only one handheld pulse oximeter. Too often, signs of distress went unnoticed, not because treatment wasn’t available, but because decline couldn’t be seen in time.
Since introducing neoGuard in 2023, every critically ill newborn in the neonatal unit has been continuously monitored. With real-time alerts and continuous data, clinicians intervene sooner, families feel reassured, and staff report a reduction in neonatal mortality, proof that technology designed for resource-limited settings can save lives.
Featured by
Articles
Articles
April 2021
Publications
Nantume A, Shah S, Cauvel T, Tomback M, Kilpatrick R, Afzal B and Kiwanuka N (2021) Developing Medical Technologies for Low-Resource Settings: Lessons From a Wireless Wearable Vital Signs Monitor–neoGuard. Front. Digit. Health 3:730951. doi: 10.3389/fdgth.2021.730951
Nantume A, Kiwanuka N, Muyinda A, Cauvel T, Shah S (2022) Accuracy and reliability of a wireless vital signs monitor for hospitalized patients in a low-resource setting. DIGITAL HEALTH. 2022;8. doi:10.1177/20552076221102262
Nantume A, Oketch BA, Otiangala D, Shah S, Cauvel T, Nyumbile B, Olayo B (2023) Feasibility, performance and acceptability of an innovative vital signs monitor for sick newborns in Western Kenya: A mixed-methods study. DIGITAL HEALTH. 2023;9. doi:10.1177/20552076231182799
Parental perceptions of a wearable vital signs monitor for observation of newborns: in-depth interviews in three tertiary hospitals, Southwest Nigeria https://www.frontiersin.org/journals/digital-health/articles/10.3389/fdgth.2025.1597651/full